Christopher J. Lindop, CFO & Vice President of at HAEMONETICS CORP (HAE), bought 217 shares at $51.81 ($11K) on 2011-11-03, disclosed to the SEC on 2011-11-07.
Scheduled purchase ($11k) by CFO & Vice President of under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HAE | SELL | 2015-08-24 | $189K | — | Filing → |
| HAE | SELL | 2015-07-21 | $192K | — | Filing → |
| HAE | SELL | 2015-06-23 | $208K | — | Filing → |